Back

Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Devices and multidisciplinary interventions in heart failure CHF - Non pharmacological treatment ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor Jean-Marc Davy

University of Montpellier, Montpellier (France)

9 More presentations in this session

Presentation thumbnail
Observed versus predicted mortality after mitraclip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation
Doctor A. Scotti (Bronx, US)
Abstract Slides Video
Presentation thumbnail
Distinct hemodynamic changes after interventional mitral valve edge to edge repair in different phenotypes of heart failure
Doctor B. Schrage (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Acute modifications of left ventricular torsional mechanics induced by cardiac resynchronization therapy affect short-term reverse remodelling
Professor P. Marino (Novara, IT)
Abstract Slides Video
Presentation thumbnail
Two-year outcomes after mitraclip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy.
Doctor A. Scotti (Bronx, US)
Abstract Slides Video
Presentation thumbnail
The role of myocardial fibrosis in the recovery of left ventricular ejection fraction after TAVI
Doctor A. Sedaghat (Bonn, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Devices and multidisciplinary interventions in heart failure

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources